# The Effect of Previous Pneumococcal Immunization on the Immune Response of Patients With Severe CKD to Prevnar 13

Study · id `cardio:ct-nct02370069` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02370069](<https://clinicaltrials.gov/study/NCT02370069>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02370069

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 138 participants.

## Technical summary

Registry record NCT02370069. Non-randomized; single masking; primary purpose prevention. Start 2015-06 (actual); primary completion 2020-08 (actual). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; single masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 138 participants (enrolled count; ClinicalTrials.gov record NCT02370069, source copy `cardio:ctgov-nct02370069-2021-09-09`, retrieved 2026-10-26)
- Started: 2015-06 (actual) (ClinicalTrials.gov record NCT02370069, source copy `cardio:ctgov-nct02370069-2021-09-09`, retrieved 2026-10-26)
- Primary completion: 2020-08 (actual) (ClinicalTrials.gov record NCT02370069, source copy `cardio:ctgov-nct02370069-2021-09-09`, retrieved 2026-10-26)
- Completion: 2020-08 (actual) (ClinicalTrials.gov record NCT02370069, source copy `cardio:ctgov-nct02370069-2021-09-09`, retrieved 2026-10-26)
- Countries: Canada (ClinicalTrials.gov record NCT02370069, source copy `cardio:ctgov-nct02370069-2021-09-09`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02370069-2021-09-09`, retrieved 2026-10-26)

## The registry's words

- Brief title: The Effect of Previous Pneumococcal Immunization on the Immune Response of Patients With Severe CKD to Prevnar 13
- Condition: Chronic Kidney Diseases
- Intervention (Biological): Prevnar 13
- Lead sponsor: Lakehead University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)

## Provenance

Content hash: 7228381fcc22910453b888efa71787417634f9d8a63c345ef010b746365ddedd
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
